{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:01:03Z","timestamp":1777327263532,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Priority Union Foundation of Yunnan Provincial Science and Technology Department and Kunming Medical University","award":["202101AC070461"],"award-info":[{"award-number":["202101AC070461"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Prod. Bioprospect."],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:sc>l<\/jats:sc>-Palmitoylcarnitine (L-PC) is an important endogenous fatty acid metabolite. Its classical biological functions are involved in the regulations of membrane molecular dynamics and the \u03b2-oxidation of fatty acids. Decreased plasma long-chain acylcarnitines showed the association of venous thrombosis, implying anticoagulant activity of the metabolites and inspiring us to investigate if and how L-PC, a long-chain acylcarnitine, takes part in coagulation. Here we show that L-PC exerted anti-coagulant effects by potentiating the enzymatic activities of plasmin and tissue plasminogen activator (tPA). L-PC directly interacts with plasmin and tPA with an equilibrium dissociation constant (KD) of 6.47\u2009\u00d7\u200910<jats:sup>\u20139<\/jats:sup> and 4.46\u2009\u00d7\u200910<jats:sup>\u20139<\/jats:sup>\u00a0M, respectively, showing high affinities. In mouse model, L-PC administration significantly inhibited FeCl<jats:sub>3<\/jats:sub>-induced arterial thrombosis. It also mitigated intracerebral thrombosis and inflammation in a transient middle cerebral artery occlusion (tMCAO) mouse model. L-PC induced little bleeding complications. The results show that L-PC has anti-thrombotic function by potentiating plasmin and tPA.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1007\/s13659-023-00413-z","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T08:02:16Z","timestamp":1699430536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["l-Palmitoylcarnitine potentiates plasmin and tPA to inhibit thrombosis"],"prefix":"10.1007","volume":"13","author":[{"given":"Juan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yepeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianlin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3262-9685","authenticated-orcid":false,"given":"Zilei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"issue":"2","key":"413_CR1","doi-asserted-by":"publisher","first-page":"103555","DOI":"10.1016\/j.sjbs.2022.103555","volume":"30","author":"AH Alhasaniah","year":"2023","unstructured":"Alhasaniah AH. l-carnitine: Nutrition, pathology, and health benefits. Saudi J Biol Sci. 2023;30(2):103555.","journal-title":"Saudi J Biol Sci"},{"issue":"9","key":"413_CR2","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3109\/0886022X.2010.510617","volume":"32","author":"F Hakeshzadeh","year":"2010","unstructured":"Hakeshzadeh F, Tabibi H, Ahmadinejad M, Malakoutian T, Hedayati M. Effects of L-Carnitine supplement on plasma coagulation and anticoagulation factors in hemodialysis patients. Ren Fail. 2010;32(9):1109\u201314.","journal-title":"Ren Fail"},{"issue":"1","key":"413_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-5793(96)00603-5","volume":"390","author":"FM Go\u00f1i","year":"1996","unstructured":"Go\u00f1i FM, Requero MA, Alonso A. Palmitoylcarnitine, a surface-active metabolite. FEBS Lett. 1996;390(1):1\u20135.","journal-title":"FEBS Lett"},{"issue":"2","key":"413_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1161\/01.RES.55.2.135","volume":"55","author":"PB Corr","year":"1984","unstructured":"Corr PB, Gross RW, Sobel BE. Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res. 1984;55(2):135\u201354.","journal-title":"Circ Res"},{"issue":"7","key":"413_CR5","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1006\/jmcc.1999.0968","volume":"31","author":"T Netticadan","year":"1999","unstructured":"Netticadan T, Yu L, Dhalla NS, Panagia V. Palmitoyl carnitine increases intracellular calcium in adult rat cardiomyocytes. J Mol Cell Cardiol. 1999;31(7):1357\u201367.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"413_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/cvr\/28.1.129","volume":"28","author":"N Inoue","year":"1994","unstructured":"Inoue N, Hirata K, Akita H, Yokoyama M. Palmitoyl-L-carnitine modifies the function of vascular endothelium. Cardiovasc Res. 1994;28(1):129\u201334.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"413_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s004249900092","volume":"438","author":"H Taki","year":"1999","unstructured":"Taki H, Muraki K, Imaizumi Y, Watanabe M. Mechanisms of the palmitoylcarnitine-induced response in vascular endothelial cells. Pflugers Arch. 1999;438(4):463\u20139.","journal-title":"Pflugers Arch"},{"issue":"1\u20132","key":"413_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0014-5793(00)01817-2","volume":"478","author":"MC Mutomba","year":"2000","unstructured":"Mutomba MC, Yuan H, Konyavko M, Adachi S, Yokoyama CB, Esser V, McGarry JD, Babior BM, Gottlieb RA. Regulation of the activity of caspases by L-carnitine and palmitoylcarnitine. FEBS Lett. 2000;478(1\u20132):19\u201325.","journal-title":"FEBS Lett"},{"issue":"3","key":"413_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1254\/jphs.92.252","volume":"92","author":"K Muraki","year":"2003","unstructured":"Muraki K, Imaizumi Y. A novel action of palmitoyl-L-carnitine in human vascular endothelial cells. J Pharmacol Sci. 2003;92(3):252\u20138.","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"413_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/rth2.12017","volume":"1","author":"H Deguchi","year":"2017","unstructured":"Deguchi H, Elias DJ, Griffin JH. Minor plasma lipids modulate clotting factor activities and may affect thrombosis risk. Res Pract Thrombosis Haemostasis. 2017;1(1):93\u2013102.","journal-title":"Res Pract Thrombosis Haemostasis"},{"key":"413_CR11","unstructured":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021; 20(10): 795\u2013820."},{"issue":"1","key":"413_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1152\/physrev.00016.2011","volume":"93","author":"HH Versteeg","year":"2013","unstructured":"Versteeg HH, Heemskerk JW, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev. 2013;93(1):327\u201358.","journal-title":"Physiol Rev"},{"issue":"5","key":"413_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41573-020-0061-0","volume":"19","author":"N Mackman","year":"2020","unstructured":"Mackman N, Bergmeier W, Stouffer GA, Weitz JI. Therapeutic strategies for thrombosis: new targets and approaches. Nat Rev Drug Discovery. 2020;19(5):333\u201352.","journal-title":"Nat Rev Drug Discovery"},{"key":"413_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","volume":"78","author":"SM Houten","year":"2016","unstructured":"Houten SM, Violante S, Ventura FV, Wanders RJ. The biochemistry and physiology of mitochondrial fatty acid \u03b2-oxidation and its genetic disorders. Annu Rev Physiol. 2016;78:23\u201344.","journal-title":"Annu Rev Physiol"},{"issue":"5 Suppl","key":"413_CR15","doi-asserted-by":"publisher","first-page":"1687s","DOI":"10.1093\/ajcn\/65.5.1687S","volume":"65","author":"HR Knapp","year":"1997","unstructured":"Knapp HR. Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr. 1997;65(5 Suppl):1687s\u201398s.","journal-title":"Am J Clin Nutr"},{"key":"413_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/BF00232574","volume":"39","author":"JP Burnier","year":"1981","unstructured":"Burnier JP, Borowski M, Furie BC, Furie B. Gamma-carboxyglutamic acid. Mol Cell Biochem. 1981;39:191\u2013207.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"413_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v6.i1.60","volume":"6","author":"M Kalafatis","year":"1996","unstructured":"Kalafatis M, Egan JO, van\u2019tVeer C, Mann KG. Regulation and regulatory role of gamma-carboxyglutamic acid containing clotting factors. Critical Rev Eukaryot Gene Express. 1996;6(1):87\u2013101.","journal-title":"Critical Rev Eukaryot Gene Express"},{"issue":"7","key":"413_CR18","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1016\/S0021-9258(19)39652-8","volume":"265","author":"S Krishnaswamy","year":"1990","unstructured":"Krishnaswamy S. Prothrombinase complex assembly. Contributions of protein-protein and protein-membrane interactions toward complex formation. J Biol Chem. 1990;265(7):3708\u201318.","journal-title":"J Biol Chem"},{"issue":"6","key":"413_CR19","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1160\/TH16-11-0829","volume":"117","author":"N Luan","year":"2017","unstructured":"Luan N, Zhou C, Li P, Ombati R, Yan X, Mo G, Rong M, Lai R, Duan Z, Zheng R. Joannsin, a novel Kunitz-type FXa inhibitor from the venom of Prospirobolus joannsi. Thromb Haemost. 2017;117(6):1031\u20139.","journal-title":"Thromb Haemost"},{"issue":"11","key":"413_CR20","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1084\/jem.20091007","volume":"206","author":"Y Decrem","year":"2009","unstructured":"Decrem Y, Rath G, Blasioli V, Cauchie P, Robert S, Beaufays J, Fr\u00e8re JM, Feron O, Dogn\u00e9 JM, Dessy C, Vanhamme L, Godfroid E. Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis. J Exp Med. 2009;206(11):2381\u201395.","journal-title":"J Exp Med"},{"issue":"27","key":"413_CR21","doi-asserted-by":"publisher","first-page":"25212","DOI":"10.1074\/jbc.M101426200","volume":"276","author":"KS Choi","year":"2001","unstructured":"Choi KS, Fitzpatrick SL, Filipenko NR, Fogg DK, Kassam G, Magliocco AM, Waisman DM. Regulation of plasmin-dependent fibrin clot lysis by annexin II heterotetramer. J Biol Chem. 2001;276(27):25212\u201321.","journal-title":"J Biol Chem"},{"issue":"5","key":"413_CR22","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00018-022-04257-7","volume":"79","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Shen C, Fang M, Han Y, Long C, Liu W, Yang M, Liu M, Zhang D, Cao Q, Chen X, Fang Y, Lu Q, Hou Z, Li Y, Liu Z, Lei X, Ni H, Lai R. Novel contact-kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke. Cell Mol Life Sci. 2022;79(5):240.","journal-title":"Cell Mol Life Sci"}],"container-title":["Natural Products and Bioprospecting"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13659-023-00413-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13659-023-00413-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13659-023-00413-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T08:25:32Z","timestamp":1699431932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13659-023-00413-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["413"],"URL":"https:\/\/doi.org\/10.1007\/s13659-023-00413-z","relation":{},"ISSN":["2192-2195","2192-2209"],"issn-type":[{"value":"2192-2195","type":"print"},{"value":"2192-2209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]},"assertion":[{"value":"18 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Care and Welfare Committee of Kunming Medical University (kmmu20211235) on 6 July 2021, and conformed to the US National Institutes of Health\u2019s Guide for the Care and Use of Laboratory Animals (National Academies Press, 8th Edition, 2011). All necessary measures were taken to ensure the welfare of the animals during the experimental protocols. The experimental C57BL\/6\u00a0J mice (males, 6\u00a0weeks old), purchased from SPF Biotechnology Co. (Beijing, China), were housed in a pathogen-free environment within sterile isolators in the laboratory under a 12\u00a0h light-12\u00a0h dark cycle at 24\u00a0\u00b0C. All mice were provided with autoclaved food and water.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}